These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


333 related items for PubMed ID: 30060079

  • 1. Characterization of Activation of the Hypothalamic-Pituitary-Adrenal Axis by the Herbicide Atrazine in the Female Rat.
    Foradori CD, Healy JE, Zimmerman AD, Kemppainen RJ, Jones MA, Read CC, White BD, Yi KD, Hinds LR, Lacagnina AF, Quihuis AM, Breckenridge CB, Handa RJ.
    Endocrinology; 2018 Sep 01; 159(9):3378-3388. PubMed ID: 30060079
    [Abstract] [Full Text] [Related]

  • 2. Characterization of the hypothalamic-pituitary-adrenal axis response to atrazine and metabolites in the female rat.
    Fraites MJ, Cooper RL, Buckalew A, Jayaraman S, Mills L, Laws SC.
    Toxicol Sci; 2009 Nov 01; 112(1):88-99. PubMed ID: 19710361
    [Abstract] [Full Text] [Related]

  • 3. Alterations in hypothalamic-pituitary-adrenal axis activity and in levels of proopiomelanocortin and corticotropin-releasing hormone-receptor 1 mRNAs in the pituitary and hypothalamus of the rat during chronic 'binge' cocaine and withdrawal.
    Zhou Y, Spangler R, Schlussman SD, Ho A, Kreek MJ.
    Brain Res; 2003 Feb 28; 964(2):187-99. PubMed ID: 12576179
    [Abstract] [Full Text] [Related]

  • 4. Chlorotriazine herbicides and metabolites activate an ACTH-dependent release of corticosterone in male Wistar rats.
    Laws SC, Hotchkiss M, Ferrell J, Jayaraman S, Mills L, Modic W, Tinfo N, Fraites M, Stoker T, Cooper R.
    Toxicol Sci; 2009 Nov 28; 112(1):78-87. PubMed ID: 19690231
    [Abstract] [Full Text] [Related]

  • 5. Atrazine does not induce pica behavior at doses that increase hypothalamic-pituitary-adrenal axis activation and cause conditioned taste avoidance.
    Hotchkiss MG, Best DS, Cooper RL, Laws SC.
    Neurotoxicol Teratol; 2012 Nov 28; 34(3):295-302. PubMed ID: 22430068
    [Abstract] [Full Text] [Related]

  • 6. The kappa-opioid receptor agonist MR-2034 stimulates the rat hypothalamic-pituitary-adrenal axis: studies in vivo and in vitro.
    Calogero AE, Scaccianoce S, Burrello N, Nicolai R, Muscolo LA, Kling MA, Angelucci L, D'Agata R.
    J Neuroendocrinol; 1996 Aug 28; 8(8):579-85. PubMed ID: 8866244
    [Abstract] [Full Text] [Related]

  • 7. Sensitization of the Hypothalamic-Pituitary-Adrenal Axis in a Male Rat Chronic Stress Model.
    Franco AJ, Chen C, Scullen T, Zsombok A, Salahudeen AA, Di S, Herman JP, Tasker JG.
    Endocrinology; 2016 Jun 28; 157(6):2346-55. PubMed ID: 27054552
    [Abstract] [Full Text] [Related]

  • 8. Corticotropin-releasing hormone and the sympathoadrenal system are major mediators in the effects of peripherally administered exendin-4 on the hypothalamic-pituitary-adrenal axis of male rats.
    Gil-Lozano M, Romaní-Pérez M, Outeiriño-Iglesias V, Vigo E, González-Matías LC, Brubaker PL, Mallo F.
    Endocrinology; 2014 Jul 28; 155(7):2511-23. PubMed ID: 24731096
    [Abstract] [Full Text] [Related]

  • 9. Chronic brain glucocorticoid receptor blockade enhances the rise in circadian and stress-induced pituitary-adrenal activity.
    van Haarst AD, Oitzl MS, Workel JO, de Kloet ER.
    Endocrinology; 1996 Nov 28; 137(11):4935-43. PubMed ID: 8895366
    [Abstract] [Full Text] [Related]

  • 10. Concomitant infusion of ovine corticotropin-releasing hormone does not prevent suppression of the hypothalamus-pituitary-adrenal axis by dexamethasone in male rats.
    Huang TS.
    J Endocrinol Invest; 1997 Nov 28; 20(7):393-6. PubMed ID: 9309537
    [Abstract] [Full Text] [Related]

  • 11. Novel in vitro perfusion system for the determination of hypothalamic-pituitary-adrenal axis responses.
    Moidel MA, Belz EE, Czambel RK, Rubin RT, Rhodes ME.
    J Pharmacol Toxicol Methods; 2006 Nov 28; 53(3):264-71. PubMed ID: 16311047
    [Abstract] [Full Text] [Related]

  • 12. Centrally administered murine-leptin stimulates the hypothalamus-pituitary- adrenal axis through arginine-vasopressin.
    Morimoto I, Yamamoto S, Kai K, Fujihira T, Morita E, Eto S.
    Neuroendocrinology; 2000 Jun 28; 71(6):366-74. PubMed ID: 10878498
    [Abstract] [Full Text] [Related]

  • 13. Adrenocorticotropin (ACTH) and corticosterone secretion by perifused pituitary and adrenal glands from rodents exposed to 2,3,7, 8-tetrachlorodibenzo-p-dioxin (TCDD).
    Pitt JA, Buckalew AR, House DE, Abbott BD.
    Toxicology; 2000 Oct 26; 151(1-3):25-35. PubMed ID: 11074297
    [Abstract] [Full Text] [Related]

  • 14. Activation of the hypothalamo-pituitary-adrenal axis by the growth hormone (GH) secretagogue, GH-releasing peptide-6, in rats.
    Thomas GB, Fairhall KM, Robinson IC.
    Endocrinology; 1997 Apr 26; 138(4):1585-91. PubMed ID: 9075719
    [Abstract] [Full Text] [Related]

  • 15. Genistein stimulates the hypothalamo-pituitary-adrenal axis in adult rats: morphological and hormonal study.
    Trifunović S, Manojlović-Stojanoski M, Ajdzanović V, Nestorović N, Ristić N, Medigović I, Milošević V.
    Histol Histopathol; 2012 May 26; 27(5):627-40. PubMed ID: 22419027
    [Abstract] [Full Text] [Related]

  • 16. Stimulation of the hypothalamo-pituitary-adrenal axis in the rat by three selective type-4 phosphodiesterase inhibitors: in vitro and in vivo studies.
    Kumari M, Cover PO, Poyser RH, Buckingham JC.
    Br J Pharmacol; 1997 Jun 26; 121(3):459-68. PubMed ID: 9179387
    [Abstract] [Full Text] [Related]

  • 17. Corticotropin secretagogues facilitate recovery of the hypothalamus-pituitary-adrenal axis suppressed by prolonged treatment with dexamethasone.
    Huang TS.
    Metabolism; 1994 May 26; 43(5):544-8. PubMed ID: 8177041
    [Abstract] [Full Text] [Related]

  • 18. Effects of fetal ethanol exposure on pituitary-adrenal sensitivity to secretagogues.
    Osborn JA, Yu C, Stelzl GE, Weinberg J.
    Alcohol Clin Exp Res; 2000 Jul 26; 24(7):1110-9. PubMed ID: 10924017
    [Abstract] [Full Text] [Related]

  • 19. Nicotinamide phosphoribosyltransferase and the hypothalamic-pituitary-adrenal axis of the rat.
    Celichowski P, Jopek K, Milecka P, Szyszka M, Tyczewska M, Malendowicz LK, Ruciński M.
    Mol Med Rep; 2018 Apr 26; 17(4):6163-6173. PubMed ID: 29436637
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 17.